Pfizer Inc. inaugurated its first commercial analytics centre, the ‘Analytics Gateway,’ in Mumbai. It also doubles up as Pfizer’s first global capability centre (GCC) and will function as the organisation’s international market outside of the US.

The centre will employ data analytics and AI solutions to improve patient outcomes and ensure the company’s growth across 140 international markets. It will also promote continuous commercial effectiveness and ensure that Pfizer uses more of its medicines for patients in India and abroad.

Pfizer’s Country President, Meenakshi Nevatia, said, “The actionable insights generated by the Analytics Gateway will power up our global commercial engine as we modernise healthcare to meet the evolving needs of patients in India and worldwide and deliver strong patient outcomes.”

Xingchu Liu, Chief Commercial Analytics and AI Officer, called the centre “an important catalyst to reshape healthcare” that will quickly deliver breakthroughs and, therefore, life-changing therapies to patients. She also expressed her confidence in the capability centre, ensuring that it will help Pfizer make “informed, data-driven decisions that will prove valuable to patients and customers around the world.”

Also Read :- Microsoft and BlackRock to Launch $30 Billion AI Infrastructure Fund

Pfizer is a well-established pharmaceutical company based in New York. It has an extensive portfolio of medicines, vaccines, and healthcare products across various therapeutic areas. The company, considered one of the largest in the pharmaceutical sector, operates globally with a presence in over 150 countries.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!